uric acid has been researched along with Cerebral Small Vessel Diseases in 4 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Cerebral Small Vessel Diseases: Pathological processes or diseases where cerebral MICROVESSELS show abnormalities. They are often associated with aging, hypertension and risk factors for lacunar infarcts (see LACUNAR INFARCTION); LEUKOARAIOSIS; and CEREBRAL HEMORRHAGE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study conducts a systematic literature review and meta-analysis regarding the potential influence of serum uric acid levels on cerebral small vessel diseases and the cognitive status in the prodromal stages of dementia." | 5.22 | The relationship between uric acid and brain health from observational studies. ( Cardoso, MA; Simó, R; Song, ZH; Tang, X; Zhou, JB, 2022) |
| "Radiological markers for cerebral small vessel disease (SVD) may have different biological underpinnings in their development." | 1.91 | Classification of white matter lesions and characteristics of small vessel disease markers. ( Hwang, SA; Jung, KH; Kim, S; Lee, EJ; Lee, WJ; Park, KI; Salat, DH, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wei, C | 1 |
| Yu, X | 1 |
| Wang, L | 1 |
| Jiang, J | 1 |
| Dai, Q | 1 |
| Kang, Y | 1 |
| Li, J | 1 |
| Chen, X | 1 |
| Tang, X | 1 |
| Song, ZH | 1 |
| Cardoso, MA | 1 |
| Zhou, JB | 1 |
| Simó, R | 1 |
| Park, KI | 1 |
| Jung, KH | 1 |
| Lee, EJ | 1 |
| Lee, WJ | 1 |
| Hwang, SA | 1 |
| Kim, S | 1 |
| Salat, DH | 1 |
| Wang, T | 1 |
| Sun, ZW | 1 |
| Shao, LQ | 1 |
| Xu, XB | 1 |
| Liu, Y | 1 |
| Qin, M | 1 |
| Weng, X | 1 |
| Zhang, YX | 1 |
1 review available for uric acid and Cerebral Small Vessel Diseases
| Article | Year |
|---|---|
The relationship between uric acid and brain health from observational studies.
Topics: Brain; Cerebral Small Vessel Diseases; Cognitive Dysfunction; Cross-Sectional Studies; Dementia; Hum | 2022 |
3 other studies available for uric acid and Cerebral Small Vessel Diseases
| Article | Year |
|---|---|
Can hyperuricemia predict the progression risk of cerebral small vessel disease?
Topics: Adult; Cerebral Small Vessel Diseases; Disease Progression; Humans; Hyperuricemia; Magnetic Resonanc | 2022 |
Classification of white matter lesions and characteristics of small vessel disease markers.
Topics: Aged; Brain; Cerebral Hemorrhage; Cerebral Small Vessel Diseases; Diabetes Mellitus; Humans; Magneti | 2023 |
Diagnostic Values of Serum Levels of Homocysteine and Uric Acid for Predicting Vascular Mild Cognitive Impairment in Patients with Cerebral Small Vessel Disease.
Topics: Aged; Case-Control Studies; Cerebral Small Vessel Diseases; Cholesterol; Cognitive Dysfunction; Fema | 2017 |